Abdala, H. | IICIMED

Abdala, H.

Publications

P52

J. Enz. Inh. Med. Chem. 2006, 21, 277-283.

3-(a-Azolylbenzyl)indoles: in vitro and in vivo anti-Leishmania activity and mechanism of action.

Pagniez, F. | Marchand, P. | Abdala, H. | Le Borgne, M. | Robert-Piessard, S. | Le Pape, P.

P47

J. Enz. Inhib. Med. Chem. 2006, 21, 305-312. 

Microtubule target for new antileishmanial drugs refered as ethyl 3-haloacetamidobenzoates.

Abdala, H. | David, S. | Bekesi, G. | Fellous, A. | Kalil, J. | Le Pape, P.

P20

J. Enz. Inh. Med. Chem. 2002, 17, 353-358.

Synthesis and antileishmanial activity of 3-(a-azolylbenzyl)indoles.

Marchand, P. | Le Borgne, M. | Na, Y.M. | Pagniez, F. | Abdala, H. | Le Baut, G. | Le Pape, P.

P15

Parasite 2002, 9, 367-370. 

In vitro and in vivo antileishmanial activity of 2-amino-4,6-dimethylpyridine derivatives against Leishmania mexicana.

Abdala, H. | Alvarez, N. | Delmas, F. | Di Giorgio, C. | Robert, J-M. | Le Baut, G. | Le Pape, P.

P7

Arzneim.-Forsch./Drug Res. 2000, 50 (I), 479-484.

Synthesis and antileishmanial activity of new 1-(pyridin-2-yl)imidazolidin-2-ones derived from 2-amino-4,6-dimethylpyridine.

Abdala, H. | Robert, J-M. | Le Pape, P. | Wielgosz, G. | Robert-Piessard, S. | Le Baut, G.

P5

Acta. Parasitologica 1999, 44, 156-159.

Activity of N-lutidinylarylcarboxamides against Leishmania donovani and L. braziliensis. 

Le Pape, P. | Abdala, H. | Pagniez, F. | Robert, J-M. | Le Baut, G.

Autres publications scientifiques

Brevets

B9.

Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition.

Le Borgne, M. | Na, Y.M. | Pagniez, F. | Le Baut, G. | Le Pape, P. | Abdala, H.

Brevet US 2004067998 A1 publié le 8 avril 2004.

B8.

Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition.

Le Borgne, M. | Na, Y.M. | Pagniez, F. | Le Baut, G. | Le Pape, P. | Abdala, H.

Brevet CN 1473160A publié le 4 février 2004.

B6.

New azolyl-substituted indole derivatives and analogs, useful as antifungal and antiparasitic drugs effective e.g. against Candida albicans, Aspergillus fumigatus and Leishmania.

Le Borgne, M. | Na, Y.M. | Pagniez, F. | Le Baut, G. | Le Pape, P. | Abdala, H.

Brevet EP 1322638 publié le 2 juillet 2003.

B5.

Indole derivatives and their use as antifungal and/or antiparasitic agents.

Le Borgne, M. | Na, Y.M. | Pagniez, F. | Le Baut, G. | Le Pape, P. | Abdala, H.

Brevet CA 2 423 151 A1 publié le 21 mars 2003.

B2.

Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition.

Le Borgne, M. | Na, Y.M. | Pagniez, F. | Le Baut, G. | Le Pape, P. | Abdala, H.


Brevet PCT WO 02/24685 A1 déposé le 21 septembre 2001, publié le 28 mars 2002.

B1.

Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux dérivés de l'indole à titre de principes actifs d'une telle composition

Le Borgne, M. | Na, Y-M. | Pagniez, F. | Le Baut, G. | Le Pape, P. | Abdala, H.

Brevet FR 2 814 073 - A1 déposé le 21 septembre 2000, publié le 22 mars 2002.

Thèse